PetIQ (Nasdaq:PETQ) - Hisse Senedi Fiyatı, Haberler ve Analizler

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

PETQ Stoklara Genel Bakış

PetIQ, Inc. Amerika Birleşik Devletleri'nde ve uluslararası alanda bir evcil hayvan ilaç ve sağlık şirketi olarak faaliyet göstermektedir.

Şirket hakkında

PETQ temel anali̇z
Kar Tanesi Skoru
Değerleme	0/6
Gelecekteki Büyüme	3/6
Geçmiş Performans	2/6
Finansal Sağlık	2/6
Temettüler	0/6

Ödüller

Kazançların yılda 59.98% oranında artması öngörülüyor

Bu yıl karlı hale geldi

Risk Analizi

Faiz ödemeleri kazançlarla iyi karşılanmıyor

Finansal sonuçları etkileyen büyük tek seferlik kalemler

Son 3 ayda dalgalı hisse senedi fiyatı

PetIQ, Inc. Rakipler

Patterson Companies

NasdaqGS:PDCO

US$1.8b

Henry Schein

NasdaqGS:HSIC

US$8.9b

Cardinal Health

NYSE:CAH

US$27.1b

Cencora

NYSE:COR

US$43.1b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti PetIQ
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	US$30.87
52 Haftanın En Yüksek Seviyesi	US$30.89
52 Haftanın En Düşük Seviyesi	US$15.09
Beta	1.74
11 Aylık Değişim	1.05%
3 Aylık Değişim	39.75%
1 Yıllık Değişim	40.19%
33 Yıllık Değişim	24.78%
5 Yıllık Değişim	16.80%
Halka arzdan bu yana değişim	32.38%

Son Haberler & Güncellemeler

Does PetIQ (NASDAQ:PETQ) Have A Healthy Balance Sheet?

Aug 14

PetIQ: Attractive Acquisition Offer After Strong Earnings Growth In Q2

Aug 09

Recent updates

PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company

Aug 16

PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet

Aug 10

PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher

Jun 14

PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital

Feb 11

PetIQ gains 1.84 % on $30M stock repurchase program

Sep 06

PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky

Aug 23

Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital

Jul 27

Is PetIQ (NASDAQ:PETQ) Using Too Much Debt?

May 06

There Are Reasons To Feel Uneasy About PetIQ's (NASDAQ:PETQ) Returns On Capital

Apr 02

The Prognosis For PetIQ

Feb 12

PetIQ: Economies Of Scale Will Kick In Eventually

Jan 03

PetIQ, Trupanion: Pet Care Industry Small Players Still Not Cheap Enough

Sep 09

Why We Think PetIQ, Inc.'s (NASDAQ:PETQ) CEO Compensation Is Not Excessive At All

Jun 23

Hissedar Getirileri

	PETQ	US Healthcare	US Pazar
7D	0.3%	-1.2%	0.1%
1Y	40.2%	8.2%	32.2%

Getiri vs. Endüstri: PETQ geçen yıl % 10.8 oranında getiri sağlayan US Healthcare sektörünü aştı.

Getiri vs Piyasa: PETQ geçen yıl % 34.1 oranında getiri sağlayan US Piyasasını aştı.

Fiyat Oynaklığı

Is PETQ's price volatile compared to industry and market?
PETQ volatility
PETQ Average Weekly Movement	13.5%
Healthcare Industry Average Movement	7.1%
Market Average Movement	6.4%
10% most volatile stocks in US Market	15.0%
10% least volatile stocks in US Market	3.1%

İstikrarlı Hisse Senedi Fiyatı: PETQ hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: PETQ 'nin haftalık oynaklığı geçtiğimiz yıl boyunca 8% dan 14% a yükseldi.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
2010	1,527	Cord Christensen	petiq.com

PetIQ, Inc. Amerika Birleşik Devletleri'nde ve uluslararası alanda bir evcil hayvan ilaç ve sağlık şirketi olarak faaliyet göstermektedir. Ürünler ve Hizmetler olmak üzere iki segmentte faaliyet göstermektedir. Şirket, pire ve kene kontrolü, kalp kurdu önleyiciler, artrit, tiroid, diyabet ve ağrı tedavileri, antibiyotikler ve diğer özel ilaçları satan Rx evcil hayvan ilaçları sunmaktadır; ve köpekler ve kediler için kendi tescilli markalı ürünlerinin yanı sıra üçüncü taraf markalı ürünler geliştirmekte ve üretmektedir.

PetIQ, Inc. Temel Bilgiler Özeti

PetIQ'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
PETQ temel i̇stati̇sti̇kler
Piyasa değeri	US$923.05m
Kazançlar(TTM)	US$13.19m
Gelir(TTM)	US$1.13b

69.4x

F/K Oranı

0.8x

P/S Oranı

PETQ aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
PETQ gelir tablosu (TTM)
Gelir	US$1.13b
Gelir Maliyeti	US$854.90m
Brüt Kâr	US$279.43m
Diğer Giderler	US$266.23m
Kazançlar	US$13.19m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	0.44
Brüt Marj	24.63%
Net Kâr Marjı	1.16%
Borç/Özkaynak Oranı	170.0%

PETQ uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

PETQ Stoklara Genel Bakış

Ödüller

Risk Analizi

PetIQ, Inc. Rakipler

NasdaqGS:PDCO

US$1.8b

NasdaqGS:HSIC

US$8.9b

NYSE:CAH

US$27.1b

NYSE:COR

US$43.1b

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Does PetIQ (NASDAQ:PETQ) Have A Healthy Balance Sheet?

PetIQ: Attractive Acquisition Offer After Strong Earnings Growth In Q2

Second quarter 2024 earnings released: EPS: US$0.52 (vs US$0.33 in 2Q 2023)

New minor risk - Share price stability

Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million.

Price target increased by 8.3% to US$30.33

Recent updates

Does PetIQ (NASDAQ:PETQ) Have A Healthy Balance Sheet?

PetIQ: Attractive Acquisition Offer After Strong Earnings Growth In Q2

Second quarter 2024 earnings released: EPS: US$0.52 (vs US$0.33 in 2Q 2023)

New minor risk - Share price stability

Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million.

Price target increased by 8.3% to US$30.33

Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million.

President & COO exercised options and sold US$483k worth of stock

PetIQ, Inc. to Report Q2, 2024 Results on Aug 07, 2024

PetIQ: Product Margin Gains Offset By Higher Marketing Spend

Insider exercised options and sold US$89k worth of stock

Independent Director recently sold US$269k worth of stock

PetIQ, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Revised Earnings Guidance for the Full Year 2024

First quarter 2024 earnings released: EPS: US$0.51 (vs US$0.33 in 1Q 2023)

PetIQ, Inc. to Report Q1, 2024 Results on May 08, 2024

PetIQ, Inc., Annual General Meeting, Jun 07, 2024

White Brook Capital - PetIQ: Guidance And Street Estimates Are Too Conservative

PetIQ (NASDAQ:PETQ) Seems To Use Debt Quite Sensibly

PetIQ, Inc. Announces Expansion of Minties Dental Treats Brand with Launch of New Dental Chew for Large-Sized Dogs

Chairman of the Board & CEO exercised options and sold US$362k worth of stock

Full year 2023 earnings released: EPS: US$0.073 (vs US$1.65 loss in FY 2022)

Petiq, Inc. Provides Sales Guidance for the First Quarter and Full Year of 2024

Chairman of the Board & CEO exercised options and sold US$154k worth of stock

PetIQ, Inc. to Report Q4, 2023 Results on Feb 28, 2024

PetIQ: Cost Savings, Higher EBITDA Suggest A Potential Valuation Re-Rate

Chief Financial Officer exercised options and sold US$97k worth of stock

PetIQ, Inc.'s New Sentry™? Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: EPS: US$0.015 (vs US$1.68 loss in 3Q 2022)

Petiq, Inc. Provides Earnings Guidance for the Full Year of 2023

PetIQ, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investors Will Want PetIQ's (NASDAQ:PETQ) Growth In ROCE To Persist

PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company

PetIQ, Inc. Revises Earnings Guidance for the Full Year 2023

PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet

Price target increased by 13% to US$27.50

Petiq, Inc. Announces Termination of R. Michael Herrman, as Executive Vice President and Corporate Secretary

PetIQ, Inc. to Report Q2, 2023 Results on Aug 08, 2023

PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher

Petiq, Inc. Provides Earnings Guidance for the Second Quarter of 2023 and Reiterates Earnings Guidance for the Full Year 2023

First quarter 2023 earnings released: EPS: US$0.33 (vs US$0.11 in 1Q 2022)

Chairman of the Board & CEO exercised options and sold US$68k worth of stock

Full year 2022 earnings released: US$1.65 loss per share (vs US$0.56 loss in FY 2021)

Price target decreased by 10% to US$21.75

PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital

PetIQ, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Third quarter 2022 earnings released: US$1.68 loss per share (vs US$0.27 loss in 3Q 2021)

Price target decreased to US$24.25

PetIQ, Inc. to Report Q3, 2022 Results on Nov 09, 2022

President & COO recently bought US$97k worth of stock

PetIQ, Inc. (NasdaqGS:PETQ) announces an Equity Buyback for $30 million worth of its shares.

PetIQ gains 1.84 % on $30M stock repurchase program

PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky

Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.14 in 2Q 2021)

PetIQ, Inc. Provides Sales Guidance for the Third Quarter and Full Year 2022

Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital

PetIQ, Inc. to Report Q2, 2022 Results on Aug 09, 2022

High number of new directors

PetIQ, Inc. Appoints John Pearson as Senior Vice President, Head of Services Division